Martin Spahn
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 50
- Prostate Cancer Diagnosis and Treatment 39
-
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 9
- Cancer, Lipids, and Metabolism 9
- Co-authors
- Burkhard KneitzSteven JoniauH. RiedmillerPaolo GonteroHendrik Van PoppelSusanne KneitzAlberto BrigantiD. Frohneberg
- Journals
- European Urology (8 papers)Journal of Clinical Oncology (7 papers)The Journal of Urology (7 papers)British Journal of Urology (6 papers)European Urology Oncology (3 papers)
- Partner nations
- GermanySwitzerlandBelgium
In The Last Decade
Martin Spahn
102 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 93
- Cancer Research 970
- Pulmonary and Respiratory Medicine 1.3k
- Rheumatology 308
- Urology 123
- Endocrinology, Diabetes and Metabolism 302
Countries citing papers authored by Martin Spahn
This map shows the geographic impact of Martin Spahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Spahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Spahn more than expected).
Fields of papers citing papers by Martin Spahn
This network shows the impact of papers produced by Martin Spahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Spahn. The network helps show where Martin Spahn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martin Spahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 21 | |
| 4 | 2023 | 11 | |
| 5 | 2021 | 1 | |
| 6 | 2017 | 13 | |
| 7 | 2015 | 98 | |
| 8 | 2015 | 0 | |
| 9 | 2014 | 106 | |
| 10 | 2014 | 206 | |
| 11 | 2013 | 64 | |
| 12 | 2012 | 31 | |
| 13 | 2012 | 27 | |
| 14 | 2010 | 0 | |
| 15 | 2010 | 189 | |
| 16 | 2010 | 27 | |
| 17 | 2009 | 189 | |
| 18 | 2008 | 5 | |
| 19 | 2001 | 12 | |
| 20 | 1998 | 6 |
About Martin Spahn
Martin Spahn is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Urology, Rheumatology and Surgery, having authored 112 papers that have together received 2.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (50 papers), Prostate Cancer Diagnosis and Treatment (39 papers), Bladder and Urothelial Cancer Treatments (20 papers), Urologic and reproductive health conditions (13 papers), MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (9 papers), Cancer, Lipids, and Metabolism (9 papers) and Urinary and Genital Oncology Studies (6 papers). The work is most often cited by research in Cancer Research (970 citations), Pulmonary and Respiratory Medicine (1.3k citations), Rheumatology (308 citations), Urology (123 citations) and Endocrinology, Diabetes and Metabolism (302 citations). Martin Spahn has collaborated with scholars based in Germany, Switzerland and Belgium. Frequent co-authors include Burkhard Kneitz, Steven Joniau, H. Riedmiller, Paolo Gontero, Hendrik Van Poppel, Susanne Kneitz, Alberto Briganti, D. Frohneberg, Claus Jürgen Scholz and R. Jeffrey Karnes. Their work appears in journals such as European Urology, Journal of Clinical Oncology, The Journal of Urology, British Journal of Urology and European Urology Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.